Viratpatil28 Sep, 2022Other
Data Bridge Market Research analyzes that the Asia-Pacific Artificial Intelligence (AI) in drug discovery market is expected to reach the value of USD 3,424.04 million by 2029, at a CAGR of 50.9% during the forecast period. Software accounts for the largest technology segment in the market due to rapid developments in technological advancements to commercialize the use of AI in drug discovery market. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
Lewis Severinsen
Firmceciley
Salisbury Orr
Nhà Cái 32win
Trang Thapcam
Howell Egeberg
Ladegaard Ogden
Buchanan Thomassen
Gamble Pilegaard
Flowers Busk